Product Code: ETC8846603 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Neuroendocrine tumors are increasingly being diagnosed in the Philippines due to improved imaging and pathology services. The market includes chemotherapy, targeted therapies, and surgical interventions, with growing interest in personalized medicine and radioligand therapy.
The Philippines Neuroendocrine Tumors (NETs) Market is expanding due to the increasing awareness and diagnosis of NETs, a rare form of cancer that affects hormone-producing cells. Treatment options, including targeted therapies and surgeries, are in demand to manage these tumors. As healthcare providers continue to improve their diagnostic capabilities and treatment options for NETs, the market for these solutions is expected to grow.
The Philippines Neuroendocrine Tumors Market struggles with underdiagnosis, limited access to targeted therapies, and insufficient awareness among healthcare providers. Neuroendocrine tumors often present non-specific symptoms, which delays diagnosis. Furthermore, treatment options such as peptide receptor radionuclide therapy (PRRT) are scarce or not widely available locally.
As diagnostic capabilities improve, the neuroendocrine tumors market is expected to expand. Specialized treatments, including targeted therapies and diagnostic imaging, are in demand. Investors can contribute through clinical trial partnerships, diagnostic services, or pharmaceutical distribution networks, especially as tertiary hospitals expand their oncology units.
Management of neuroendocrine tumors (NETs) is guided by policies for cancer care under the National Integrated Cancer Control Act. The DOH and PhilHealth offer support for diagnostics, surgery, and select drug therapies for NETs through government hospitals. The FDA oversees the availability and regulation of somatostatin analogs and advanced treatments. Cancer registries are being improved to better capture rare cancers like NETs and support funding and clinical research.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Neuroendocrine Tumors Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Neuroendocrine Tumors Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Neuroendocrine Tumors Market - Industry Life Cycle |
3.4 Philippines Neuroendocrine Tumors Market - Porter's Five Forces |
3.5 Philippines Neuroendocrine Tumors Market Revenues & Volume Share, By Classification, 2021 & 2031F |
3.6 Philippines Neuroendocrine Tumors Market Revenues & Volume Share, By Site, 2021 & 2031F |
3.7 Philippines Neuroendocrine Tumors Market Revenues & Volume Share, By Grade, 2021 & 2031F |
3.8 Philippines Neuroendocrine Tumors Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.9 Philippines Neuroendocrine Tumors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.10 Philippines Neuroendocrine Tumors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Philippines Neuroendocrine Tumors Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Philippines Neuroendocrine Tumors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Neuroendocrine Tumors Market Trends |
6 Philippines Neuroendocrine Tumors Market, By Types |
6.1 Philippines Neuroendocrine Tumors Market, By Classification |
6.1.1 Overview and Analysis |
6.1.2 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Classification, 2021- 2031F |
6.1.3 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Functional Net, 2021- 2031F |
6.1.4 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Non-Functional Net, 2021- 2031F |
6.2 Philippines Neuroendocrine Tumors Market, By Site |
6.2.1 Overview and Analysis |
6.2.2 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Lung, 2021- 2031F |
6.2.3 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Pancreas, 2021- 2031F |
6.2.4 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Gastrointestinal Tract (GI), 2021- 2031F |
6.2.5 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Appendicular, 2021- 2031F |
6.3 Philippines Neuroendocrine Tumors Market, By Grade |
6.3.1 Overview and Analysis |
6.3.2 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Grade 1, 2021- 2031F |
6.3.3 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Low-Grade Tumor, 2021- 2031F |
6.3.4 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Grade 2, 2021- 2031F |
6.3.5 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Intermediate-Grade Tumor, 2021- 2031F |
6.3.6 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Grade 3, 2021- 2031F |
6.3.7 Philippines Neuroendocrine Tumors Market Revenues & Volume, By High-Grade Tumor, 2021- 2031F |
6.4 Philippines Neuroendocrine Tumors Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.4.3 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Treatment, 2021- 2031F |
6.5 Philippines Neuroendocrine Tumors Market, By Product |
6.5.1 Overview and Analysis |
6.5.2 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Somatostatin Analogs, 2021- 2031F |
6.5.3 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.5.4 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Tyrosine Kinase Inhibitors, 2021- 2031F |
6.5.5 Philippines Neuroendocrine Tumors Market Revenues & Volume, By mTOR Inhibitors, 2021- 2031F |
6.5.6 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.5.7 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Antimetabolites, 2021- 2031F |
6.5.8 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.5.9 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.6 Philippines Neuroendocrine Tumors Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.7 Philippines Neuroendocrine Tumors Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.7.4 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.5 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.6 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Others, 2021- 2031F |
6.8 Philippines Neuroendocrine Tumors Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.8.3 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.8.4 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.5 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.6 Philippines Neuroendocrine Tumors Market Revenues & Volume, By Other, 2021- 2031F |
7 Philippines Neuroendocrine Tumors Market Import-Export Trade Statistics |
7.1 Philippines Neuroendocrine Tumors Market Export to Major Countries |
7.2 Philippines Neuroendocrine Tumors Market Imports from Major Countries |
8 Philippines Neuroendocrine Tumors Market Key Performance Indicators |
9 Philippines Neuroendocrine Tumors Market - Opportunity Assessment |
9.1 Philippines Neuroendocrine Tumors Market Opportunity Assessment, By Classification, 2021 & 2031F |
9.2 Philippines Neuroendocrine Tumors Market Opportunity Assessment, By Site, 2021 & 2031F |
9.3 Philippines Neuroendocrine Tumors Market Opportunity Assessment, By Grade, 2021 & 2031F |
9.4 Philippines Neuroendocrine Tumors Market Opportunity Assessment, By Type, 2021 & 2031F |
9.5 Philippines Neuroendocrine Tumors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.6 Philippines Neuroendocrine Tumors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Philippines Neuroendocrine Tumors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Philippines Neuroendocrine Tumors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Neuroendocrine Tumors Market - Competitive Landscape |
10.1 Philippines Neuroendocrine Tumors Market Revenue Share, By Companies, 2024 |
10.2 Philippines Neuroendocrine Tumors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |